← Leaderboards
Zheng-Rong Lu
Case Western Reserve University
$13,267,567
Attributed
$15,177,547
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,177,547 · 11
By mechanism
R01$13,440,820 · 6
R33$873,383 · 1
R21$576,207 · 2
R41$287,137 · 2
Top collaborators
- William Schiemann7 shared
- Li Lily Wang1 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIn VivoContrast MediaMagnetic Resonance ImagingTissuesDesignAnimal ModelMalignant NeoplasmsEffectivenessDiagnosisLeadSafetyBaseCessation Of LifeLifeDrug KineticsToxic EffectNanoparticleAnimalsAdverse EffectsNeoplasm MetastasisCancer CellCancer ImagingCancer Patient
Grant awards (49)
Anticancer ELNP nanovaccines for curative treatmentof pancreatic cancer$654,681
R01 · FY2025 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$405,115
R01 · FY2025 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$405,116
R01 · FY2024 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$349,785
R01 · FY2023 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$75,403
R01 · FY2023 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$350,213
R01 · FY2022 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$74,657
R01 · FY2022 · CA · contact PI
Targeted MRI contrast agents for differential diagnosis of prostate cancer$426,881
R01 · FY2021 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$357,780
R01 · FY2021 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$23,693
R01 · FY2021 · CA · contact PI
Targeted MRI contrast agents for differential diagnosis of prostate cancer$426,240
R01 · FY2020 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$356,947
R01 · FY2020 · CA · contact PI
Image-guided EMT inhibition for treating metastatic breast cancer$459,637
R01 · FY2019 · CA · contact PI
Targeted MRI contrast agents for differential diagnosis of prostate cancer$411,586
R01 · FY2019 · CA · contact PI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy$356,444
R01 · FY2019 · CA · contact PI
Image-guided EMT inhibition for treating metastatic breast cancer$473,853
R01 · FY2018 · CA · contact PI
Targeted MRI contrast agents for differential diagnosis of prostate cancer$424,315
R01 · FY2018 · CA · contact PI
Image-guided EMT inhibition for treating metastatic breast cancer$473,853
R01 · FY2017 · CA · contact PI
Targeted MRI contrast agents for differential diagnosis of prostate cancer$423,352
R01 · FY2017 · CA · contact PI
Image-guided EMT inhibition for treating metastatic breast cancer$473,853
R01 · FY2016 · CA · contact PI
Image-guided EMT inhibition for treating metastatic breast cancer$473,853
R01 · FY2015 · CA · contact PI
Biodegradable macromolecular CT contrast agents$233,038
R21 · FY2015 · EB · contact PI
Biodegradable Macromolecular Blood Pool Contrast Agents$336,274
R01 · FY2014 · EB · contact PI
Biodegradable macromolecular CT contrast agents$193,659
R21 · FY2014 · EB · contact PI
Biodegradable Macromolecular Blood Pool Contrast Agents$326,976
R01 · FY2013 · EB · contact PI
Biodegradable Macromolecular Blood Pool Contrast Agents$346,804
R01 · FY2012 · EB · contact PI
Biodegradable Macromolecular Blood Pool Contrast Agents$346,868
R01 · FY2011 · EB · contact PI
Polymer chelate conjugates for diagnostic cancer imaging$243,664
R01 · FY2011 · CA · contact PI
Biodegradable macromolecular Blood pool contrast agents$274,179
R01 · FY2010 · EB · contact PI
Polymer chelate conjugates for diagnostic cancer imaging$251,200
R01 · FY2010 · CA · contact PI
Polymer chelate conjugates for diagnostic cancer imaging$376,079
R01 · FY2009 · CA · contact PI
Biodegradable macromolecular Blood pool contrast agents$276,948
R01 · FY2009 · EB · contact PI
Polymer chelate conjugates for diagnostic cancer imaging$251,200
R01 · FY2009 · CA · contact PI
Multifunctional Carriers for Systemic siRNA Delivery$137,575
R41 · FY2009 · CA · contact PI
Biodegradable macromolecular Blood pool contrast agents$263,718
R01 · FY2008 · EB · contact PI
Polymer chelate conjugates for diagnostic cancer imaging$240,800
R01 · FY2008 · CA · contact PI
Minimally-Invasive Image-Guided Therapy for Cancer Treatment$149,562
R41 · FY2008 · CA · contact PI
Biodegradable macromolecular Blood pool contrast agents$269,100
R01 · FY2007 · EB · contact PI
Polymer chelate conjugates for Diagnostic cancer imaging$232,475
R01 · FY2007 · CA · contact PI
Biodegradable Macromolecular MRI Contrast Agents$284,772
R33 · FY2006 · CA · contact PI
Polymer chelate conjugates for Diagnostic cancer imaging$239,418
R01 · FY2006 · CA · contact PI
Biodegradable Macromolecular MRI Contrast Agents$283,134
R33 · FY2005 · CA
Biodegradable macromolecular blood pool contrast agents$261,625
R01 · FY2005 · EB
Polymer chelate conjugates for Diagnostic cancer imaging$245,180
R01 · FY2005 · CA
Biodegradable Macromolecular MRI Contrast Agents$305,477
R33 · FY2004 · CA
Biodegradable macromolecular blood pool contrast agents$261,625
R01 · FY2004 · EB
Polymer chelate conjugates for Diagnostic cancer imaging$232,805
R01 · FY2004 · CA
Biodegradable macromolecular blood pool contrast agents$286,625
R01 · FY2003 · EB
Biodegradable Macromolecular MRI Contrast Agents$149,510
R21 · FY2003 · CA